Ishan is a freshman at Vanderbilt University, originally from the Bay Area of California. He is majoring in biochemistry and philosophy on the pre-med track. Throughout high school, he was heavily involved in research related to antibody-drug-conjugates, something which he hopes to be involved with in the future. During his free time, he enjoys watching TV shows and spending time with his family.
Dr. Manson received his MSc in Molecular Medicine from Cranfield University, United Kingdom and a PhD in Molecular Biology and Biotechnology, jointly awarded by the Pan African University and Jomo Kenyatta University of Agriculture & Technology, Kenya. His doctoral research pioneered the development of monoclonal antibodies targeting cytotoxic three-finger toxin proteins in cobra venom, contributing to advancements in snakebite therapeutics. This work resulted in three peer-reviewed publications and one book chapter. Prior to joining Dr. Crowe's laboratory as a postdoctoral research fellow in January 2026, he worked at the intersection of vaccine research, pharmaceutical manufacturing development and national skills strengthening as a technical advisor on the German Development Corporation (GIZ) PharmaVax Ghana Programme. There, he supported Ghana's transition towards sustainable local vaccine production, workforce capacity enhancement and R&D-driven policy development.
Yan Su is an experienced biomedical researcher with more than 20 years of academic and clinical expertise across immunology, molecular pathogenesis, and in vivo disease modeling. Trained as an M.D. at Chongqing Medical University, she began her career as a dermatologist and later transitioned into biomedical research in the United States. Since 2002, she has led and independently conducted extensive mouse model studies involving immune regulation, antigen processing, kidney injury, fibrosis, and diabetic and chronic kidney diseases.
At Vanderbilt University, she has contributed to multiple research programs, providing expertise in molecular biology, immunology, and complex surgical and genetic mouse models. She has co-authored scientific publications, trained graduate students and fellows, and supported high-functioning laboratory operations. Her work reflects a strong commitment to advancing translational research that improves human health.
Bridget Litts attended Syracuse University where she also worked as an undergraduate researcher at Upstate University studying embryonic left-right patterning and heart development using a zebrafish model. After graduating with a Bachelor of Science degree in Molecular Biology in 2014, she interned at Kentucky Equine Research where she studied the long-term effects of Lasix administration on exercise recovery in racehorses. She then joined the Davies lab at Cincinnati Children’s Hospital as part of a biobanking team that collected and processed samples from consented children undergoing bone marrow transplant. She became the point of contact for a collaboration with St. Jude’s, the childhood cancer survivor study, which involved isolating and banking DNA from thousands of saliva and blood samples. In 2020, she joined the Stafford Lab at Vanderbilt as Lab Manager where she studied the combined effect of high fat diet and moderate alcohol consumption on liver lipid metabolism.
Ariel Pruchnicki is a Laboratory manager for the VCAT. She is a graduate of Central Connecticut University where she studied Biology. She has a certificate in project management and supply chain management and analytics. Ariel comes from Florida with 10 years of industry experience.